Serum hs-CRP, YKL-40 and brain-derived neurotrophic factor (BDNF) associated biomarkers in non-dipper hypertension profile?
Authors:
Ioan Ţilea, Andreea Varga, Septimiu Voidăzan, Adina Huţanu
14
Postoperative interleukin-8 levels are related to the duration of coronary artery bypass grafting surgery and predict in-hospital postsurgical complications
IL-6 gene polymorphisms and sepsis in ICU adult Romanian patients: a prospective study
Authors:
Anca Meda Georgescu, Claudia Bănescu, Iudita Badea, Valeriu Moldovan, Adina Huțanu, Septimiu Voidăzan, Minodora Dobreanu, Leonard Azamfirei
18
CXCL13 levels are more increased in cerebrospinal fluid and plasma of patients with acute infectious than in non-infectious diseases of the central nervous system
Ang-2, Tie-2, and Ang-2/Tie-2 ratio serum levels as diagnostic and prognostic biomarkers of sepsis in critically ill patients
Authors:
János Szederjesi, Anca Georgescu, Ario Santini, Emőke Almásy, Alexandra Lazar, Adina Hutanu, Sanda-Maria Copotoiu, Leonard Azamfirei
21
Vitamin D plasma levels in a Romanian group of HIV-infected patients
Authors:
Marta Andrea Fodor, Iringó Erzsébet Zaharia-Kézdi, Brînduşa Ţilea, Anca Georgescu, Cristina Gîrbovan, Andrea Incze, Nina Şincu, Adina Huţanu, Enikő Nemes-Nagy, Carmen Luminita Chiriac
22
Soluble urokinase-type plasminogen activator receptor (suPAR) – a possible biomarker for bacteremia in sepsis
Authors:
Anca-Meda Georgescu, Janos Szederjesi, Septimiu Voidazan, Minodora Dobreanu, Sanda Maria Copotoiu, Adina Hutanu, Leonard Azamfirei
23
Comparing the Anti-Inflammatory Effects of Simvastatin and Rosuvastatin by Measuring IL-1β, IL-6 and TNF-α Levels Using a Murinic Caecal Ligation And Puncture Induced Sepsis Model
Authors:
Mihai Mărginean, Sebastian Trancă, Alina Ardelean-Maghiar (Mărginean), Dan Dîrzu, Adina Huțanu, Oana Platon (Antal), Dan Dobreanu
24
Assessment of beta cell function in subjects with newly diagnosed type 2 diabetes
Incidence and clinical significance of binding antibodies and their relationships with neutralizing antibodies, both induced by interferon-β treatment in multiple sclerosis patients